Publications by authors named "Carlos Barea"

Claim this Profile
N
New hydrazine and hydrazide quinoxaline 1,4-di-N-oxide derivatives: In silico ADMET, antiplasmodial and antileishmanial activity.
Miguel Quiliano, Adriana Pabón, Gustavo Ramirez-Calderon, Carlos Barea, Eric Deharo

Bioorg Med Chem Lett· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New amide derivatives of quinoxaline 1,4-di-N-oxide with leishmanicidal and antiplasmodial activities.
Carlos Barea, Adriana Pabón, Silvia Pérez-Silanes, Silvia Galiano, German Gonzalez

Molecules· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiplasmodial and leishmanicidal activities of 2-cyano-3-(4-phenylpiperazine-1-carboxamido) quinoxaline 1,4-dioxide derivatives.
Carlos Barea, Adriana Pabón, Silvia Galiano, Silvia Pérez-Silanes, German Gonzalez

Molecules· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities.
Carlos Barea, Adriana Pabón, Denis Castillo, Mirko Zimic, Miguel Quiliano

Bioorg Med Chem Lett· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents.
Enrique Torres, Elsa Moreno, Saioa Ancizu, Carlos Barea, Silvia Galiano

Bioorg Med Chem Lett· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis